HopeStage
Back to all studies
CompletedNCT05870605

Intuniv prescribing patterns across European countries

About this titleRead the official source — NCT05870605
Observational studyAges 6+GermanyADHD
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 6 years.

Listed locations
MunichSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: November 15, 2018
Recruitment status
Completed
Enrollment listed in the registry
5,000
Sponsor
Shire
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Other
Locations
Germany
Age range
Over 6 Years
Official registry ID
NCT05870605
Official title
Show the full official title

Drug Utilisation Study of Intuniv® (Guanfacine Extended Release) in European Countries

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Munich

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Shire.

Who was this study for?

Listed age limits: from 6 years.

Want to explore more studies?

Explore studies